By Drug Target Review2024-07-18T12:00:17
Researchers screened over 2,000 small molecules and have now more than doubled the known compounds reported to induce trained immunity.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-26T13:58:00Z
2026-03-18T14:47:08Z
2024-01-09T10:09:08
Sponsored by Sartorius iQue®
2023-07-04T10:05:58
Sponsored by Revvity
2023-03-07T10:55:58
Sponsored by Agilent
2024-01-26T13:22:42
Sponsored by bit.bio
2024-05-07T13:11:19
Sponsored by BellBrook Labs
2023-07-11T16:13:06
Sponsored by Agilent
Site powered by Webvision Cloud